Patent Assignment
Reel/Frame 014271/0664
Assignment of Assignor's Interest
Recorded: 2004-01-20
Pages: 4
Assignor
WASHINGTON UNIVERSITY
Executed: 2004-01-05
Assignee
AVANT IMMUNOTHERAPEUTICS, INC.
119 FOURTH AVENUE, NEEDHAM, MASSACHUSETTS, 02494-2725
Covered Properties
(4)
Recombinant Bacterial Vaccine System with Environmentally Limited Viability
Application:
08/473,789 →
Recombinant Bacterial System with Environmentally Limited Viability
Patent:
6,610,529 →
Application:
08/761,769 →
Recombinant Bacterial Vaccine System with Environmentally Limited Viability
Patent:
7,871,604 →
Application:
09/120,970 →
Recombinant bacterial system with environmentally limited viability
Application:
10/620,777 →
Publication:
US 2004/0208897
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 10, 1995
From: CURTISS, ROY III; TINGE, STEVEN A.
To: WASHINGTON UNIVERSITY
Reel/Frame 007600/0008 →
Assignment of Assignor's Interest
Feb 10, 1997
From: CURTISS, ROY III; TINGE, STEVEN A.
To: WASHINGTON UNIVERSITY
Reel/Frame 008413/0682 →
Confirmatory License
Aug 29, 2008
From: WASHINGTON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021465/0521 →
Confirmatory License
Aug 29, 2008
From: WASHINGTON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021465/0523 →
Change of Name
Mar 9, 2009
From: AVANT IMMUNOTHERAPEUTICS, INC. (NEEDHAM, MASSACHUSETTS)
To: CELLDEX THERAPEUTICS, INC.
Reel/Frame 022380/0239 →
Assignment of Assignor's Interest
Oct 27, 2010
From: CURTISS III, ROY; TINGE, STEVEN A.
To: WASHINGTON UNIVERSITY
Reel/Frame 025206/0627 →
Assignment of Assignor's Interest
Nov 4, 2010
From: CELLDEX THERAPEUTICS, INC.
To: WASHINGTON UNIVERSITY
Reel/Frame 025310/0058 →
Assignment of Assignor's Interest
Jun 10, 2011
From: CELLDEX THERAPEUTICS, INC.
To: WASHINGTON UNIVERSITY
Reel/Frame 026426/0263 →